Lack of Evidence for mtDNA as a Biomarker of Innate Immune Activation in HIV Infection

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Lauring, Adam S ^a,b,c   Lee, Tzong Hae ^b   Martin, Jeffrey N ^a   Hunt, Peter W ^a   Deeks, Steven G ^a   Busch, Michael ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; MITOCHONDRIAL DNA;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; CELL DEATH; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DNA DETERMINATION; DRUG EFFECT; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MIXED INFECTION; PROCESS DEVELOPMENT; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DNA, MITOCHONDRIAL; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; MALE; POLYMERASE CHAIN REACTION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84870500260     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050486     Document Type: Article

References (30)

1. Douek DC, Roederer M, Koup RA, (2009) Emerging concepts in the immunopathogenesis of AIDS. Annual review of medicine 60: 471-484 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18947296&retmode=ref&cmd=prlinks.
2. Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, et al. (2000) T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95: 249-255 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=10607709&retmode=ref&cmd=prlinks.
3. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, et al. (1999) Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature medicine 5: 83-89 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=9883844&retmode=ref&cmd=prlinks.
4. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, et al. (1983) Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. The New England journal of medicine 309: 453-458 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=6224088&retmode=ref&cmd=prlinks.
5. Valdez H, Lederman MM (1997) Cytokines and cytokine therapies in HIV infection. AIDS clinical review: 187-228. Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=9305449&retmode=ref&cmd=prlinks.
6. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J INFECT DIS 179: 859-870 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=10068581&retmode=ref&cmd=prlinks.
7. Deeks SG, Kitchen CMR, Liu L, Guo H, Gascon R, et al. (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=15117761&retmode=ref&cmd=prlinks.
8. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, et al. (2003) T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J INFECT DIS 187: 1534-1543 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=12721933&retmode=ref&cmd=prlinks.
9. Hunt PW, Cao HL, Muzoora C, Ssewanyana I, Bennett J, et al. (2011) Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 25: 2123-2131 doi:10.1097/QAD.0b013e32834c4ac1.
10. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, et al. (2008) Relationship between T Cell Activation and CD4+T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy. J INFECT DIS 197: 126-133 doi:10.1086/524143.
11. Deeks SG, (2011) HIV Infection, Inflammation, Immunosenescence, and Aging. Annual review of medicine 62: 141-155 Available:http://www.annualreviews.org/doi/abs/10.1146/annurev-med-042909-093756.
12. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, et al. (2012) HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 60 (Suppl 1): S1-S18 doi:10.1097/QAI.0b013e31825a3668.
13. Kalayjian RC, Landay A, Pollard RB, Taub DD, Gross BH, et al. (2003) Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J INFECT DIS 187: 1924-1933 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=12792869&retmode=ref&cmd=prlinks.
14. Plaeger SF, Collins BS, Musib R, Deeks SG, Read S, et al. (2011) Immune Activation in the Pathogenesis of Treated Chronic HIV Disease: A Workshop Summary. AIDS Res Hum Retroviruses: 110927130746001. Available:http://www.liebertonline.com/doi/abs/10.1089/aid.2011.0213.
15. Brenchley JM, Price DA, Douek DC, (2006) HIV disease: fallout from a mucosal catastrophe? Nature immunology 7: 235-239 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=16482171&retmode=ref&cmd=prlinks.
16. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature medicine 12: 1365-1371 Available:http://www.nature.com/nm/journal/v12/n12/abs/nm1511.html.
17. Iwasaki A, Medzhitov R, (2010) Regulation of adaptive immunity by the innate immune system. Science (New York, NY) 327: 291-295 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=20075244&retmode=ref&cmd=prlinks.
18. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science (New York, NY) 285: 248-251 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=10398600&retmode=ref&cmd=prlinks.
19. Scaffidi P, Misteli T, Bianchi ME, (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=12110890&retmode=ref&cmd=prlinks.
20. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, et al. (2009) Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Critical care (London, England) 13: R174 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19887013&retmode=ref&cmd=prlinks.
21. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, et al. (2011) Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends in immunology 32: 157-164 Available:http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21334975&retmode=ref&cmd=prlinks.
22. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107 Available:http://www.nature.com/nature/journal/v464/n7285/full/nature08780.html.
23. Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, et al. (2006) Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses 22: 757-762 doi:10.1089/aid.2006.22.757.
24. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, et al. (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17: 1871-1879 doi:10.1097/01.aids.0000076308.76477.b8.
25. Fiebig EW, Heldebrant CM, Smith RIF, Conrad AJ, Delwart EL, et al. (2005) Intermittent low-level viremia in very early primary HIV-1 infection. J Acquir Immune Defic Syndr 39: 133-137.
26. Corash L, Tan H, Gralnick HR, (1977) Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood 49: 71-87.
27. Corash L, Costa JL, Shafer B, Donlon JA, Murphy D, (1984) Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood 64: 185-193.
28. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, et al. (2012) Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485: 251-255 Available:http://dx.doi.org/10.1038/nature10992.
29. Côté HCF, Brumme ZL, Craib KJP, Alexander CS, Wynhoven B, et al. (2002) Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. Available:http://content.nejm.org/cgi/content/abstract/346/11/811.
30. Cherry CL, Wesselingh SL, (2003) Nucleoside analogues and HIV: the combined cost to mitochondria. The Journal of antimicrobial chemotherapy 51: 1091-1093 doi:10.1093/jac/dkg203.